Literature DB >> 19526197

PIAS proteins: pleiotropic interactors associated with SUMO.

Miia M Rytinki1, Sanna Kaikkonen, Petri Pehkonen, Tiina Jääskeläinen, Jorma J Palvimo.   

Abstract

The interactions and functions of protein inhibitors of activated STAT (PIAS) proteins are not restricted to the signal transducers and activators of transcription (STATs), but PIAS1, -2, -3 and -4 interact with and regulate a variety of distinct proteins, especially transcription factors. Although the majority of PIAS-interacting proteins are prone to modification by small ubiquitin-related modifier (SUMO) proteins and the PIAS proteins have the capacity to promote the modification as RING-type SUMO ligases, they do not function solely as SUMO E3 ligases. Instead, their effects are often independent of their Siz/PIAS (SP)-RING finger, but dependent on their capability to noncovalently interact with SUMOs or DNA through their SUMO-interacting motif and scaffold attachment factor-A/B, acinus and PIAS domain, respectively. Here, we present an overview of the cellular regulation by PIAS proteins and propose that many of their functions are due to their capability to mediate and facilitate SUMO-linked protein assemblies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526197     DOI: 10.1007/s00018-009-0061-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  139 in total

1.  BIND: the Biomolecular Interaction Network Database.

Authors:  Gary D Bader; Doron Betel; Christopher W V Hogue
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

3.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

4.  Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.

Authors:  Xuan Zhao; Thomas Sternsdorf; Timothy A Bolger; Ronald M Evans; Tso-Pang Yao
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.

Authors:  N Kotaja; S Aittomäki; O Silvennoinen; J J Palvimo; O A Jänne
Journal:  Mol Endocrinol       Date:  2000-12

6.  Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.

Authors:  Stefan Weger; Eva Hammer; Regine Heilbronn
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

7.  PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.

Authors:  Shen-Hsi Yang; Andrew D Sharrocks
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

8.  PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity.

Authors:  Bin Liu; Sheldon Mink; Kelly A Wong; Natalie Stein; Crescent Getman; Paul W Dempsey; Hong Wu; Ke Shuai
Journal:  Nat Immunol       Date:  2004-08-15       Impact factor: 25.606

9.  The small ubiquitin-like modifier (SUMO) is required for gonadal and uterine-vulval morphogenesis in Caenorhabditis elegans.

Authors:  Limor Broday; Irina Kolotuev; Christine Didier; Anindita Bhoumik; Bhagwati P Gupta; Paul W Sternberg; Benjamin Podbilewicz; Ze'ev Ronai
Journal:  Genes Dev       Date:  2004-10-01       Impact factor: 11.361

10.  PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.

Authors:  Susanne Weber; Florian Maass; Michael Schuemann; Eberhard Krause; Guntram Suske; Uta-Maria Bauer
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

View more
  128 in total

1.  Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.

Authors:  Hyunju Ryu; Yoshiaki Azuma
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

2.  SUMO wrestling in cell movement.

Authors:  Miia M Rytinki; Jorma J Palvimo
Journal:  Cell Res       Date:  2010-11-23       Impact factor: 25.617

Review 3.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

4.  PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.

Authors:  Toru Kubota; Mayumi Matsuoka; Songxiao Xu; Noriyuki Otsuki; Makoto Takeda; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

5.  Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.

Authors:  Minghua Nie; Michael N Boddy
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

Review 6.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

Review 7.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

8.  SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.

Authors:  Seong Won Lee; Moon Hee Lee; Jong Ho Park; Sung Hwan Kang; Hee Min Yoo; Seung Hyun Ka; Young Mi Oh; Young Joo Jeon; Chin Ha Chung
Journal:  EMBO J       Date:  2012-10-23       Impact factor: 11.598

9.  Signaling by retinol and its serum binding protein.

Authors:  Noa Noy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-10-29       Impact factor: 4.006

10.  Up-regulation of SUMO E3 ligases during lung schistosomula and adult worm stages.

Authors:  Roberta V Pereira; Matheus de S Gomes; Fernanda Janku Cabral; Liana K Jannotti-Passos; Vanderlei Rodrigues; William de Castro-Borges; Renata Guerra-Sá
Journal:  Parasitol Res       Date:  2014-05-07       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.